MIST
Milestone Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$214.15M
P/E Ratio
—
EPS
$-0.75
Beta
0.69
52W High
$3.06
52W Low
$1.00
50-Day MA
$1.68
200-Day MA
$1.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
Fundamentals
| Revenue (TTM) | $1.55M |
| Gross Profit (TTM) | $1.55M |
| EBITDA | $-62.03M |
| Operating Margin | -1116.00% |
| Return on Equity | -229.60% |
| Return on Assets | -41.10% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.34 |
| Price-to-Book | 5.13 |
| Price-to-Sales (TTM) | 138.52 |
| EV/Revenue | 107.74 |
| EV/EBITDA | -1.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $117.67M |
| Float | $14.07M |
| % Insiders | 2.52% |
| % Institutions | 27.13% |
Historical Volatility
HV 10-Day
53.98%
HV 20-Day
87.12%
HV 30-Day
126.54%
HV 60-Day
96.80%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($6.50 target)
1
Strong Buy3
Buy1
HoldData last updated: 4/30/2026